Skip to main content

Find Clinical Trials

Home
Conditions
Adenocarcinoma

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

126 public trials 17 recruiting studies

Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Completed

Study of Motexafin Gadolinium (MGd) for Second Line Treatment of Non-Small-Cell Lung Cancer

NCT00129844

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +12 more
Locations: Fountain Valley, California, United States

Los Angeles, California, United States

Palm Springs, California, United States

Columbia, Missouri, United States

View all 16 locations

View Trial Details

Completed

A Long Term Safety Study With Atrasentan

NCT00127478

Conditions: Adenocarcinoma, Carcinoma, Genital Diseases, +12 more
Locations: Prostate Oncology Specialists Marina del Rey, California, United States

Western Clinical Research, Inc. Torrance, California, United States

South Florida Medical Research Aventura, Florida, United States

Beth Isreal Medical Center, Phillips Ambulatory Care Ceneter New York, United States

View all 15 locations

View Trial Details

Completed

Gemcitabine and Pemetrexed in Primary Unknown Adenocarcinoma

NCT00191503

Conditions: Adenocarcinoma, Carcinoma, Neoplasms, +2 more
Locations: For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Calgary, Alberta, Canada

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Edmonton, Alberta, Canada

View Trial Details

Completed

Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer

NCT00054873

Conditions: Adenocarcinoma, Adenocarcinoma Of Esophagus, Carcinoma, +13 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

ACRC/Arizona Clinical Research Center Tucson, Arizona, United States

Glendale Memorial Hospital Glendale, California, United States

USC/Norris Comprehensive Cancer Center Los Angeles, California, United States

View all 29 locations

View Trial Details

Completed

Phase I Study of a Monoclonal Antibody for Treatment of Advanced Adenocarcinomas

NCT00051675

Conditions: Adenocarcinoma, Carcinoma, Neoplasms, +2 more
Locations: Jack D. Weiler Hospital of the Albert Einstein College of Medicine The Bronx, New York, United States

View Trial Details

Terminated

Using a PET Imaging Agent, 18F-Clofarabine (CFA), to Measure Deoxycytidine Kinase Activity in Metastatic Cancer

NCT05065736

Conditions: Adenocarcinoma, Carcinoma, Metastatic Cancer, +7 more
Locations: Cleveland Clinic, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details